¹H-NMR and ¹³C-NMR dataset for some oxidative metabolites of CRA13 and their analogs.

ABSTRACT: CRA13 (CB-13; SAB-378) is a dual CB₁R/CB₂R agonist cannabinoid agent developed by Novartis Pharma. Upon administration, it undergoes metabolism to oxidative metabolites. Herein, the ¹H-NMR and ¹³C-NMR dataset of some oxidative metabolites and analogs thereof are presented for further analysis and comparison purposes, for whom may be interested.

SUBMITTER: Hassan AHE 

PROVIDER: S-EPMC6198130 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature